These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 24307240
1. Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007. Hallander H, Advani A, Alexander F, Gustafsson L, Ljungman M, Pratt C, Hall I, Gorringe AR. Clin Vaccine Immunol; 2014 Feb; 21(2):165-73. PubMed ID: 24307240 [Abstract] [Full Text] [Related]
2. Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR. Clin Vaccine Immunol; 2012 Nov; 19(11):1776-83. PubMed ID: 22956654 [Abstract] [Full Text] [Related]
3. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L. APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126 [Abstract] [Full Text] [Related]
4. Bordetella pertussis isolates in Finland: serotype and fimbrial expression. Heikkinen E, Xing DK, Olander RM, Hytönen J, Viljanen MK, Mertsola J, He Q. BMC Microbiol; 2008 Sep 25; 8():162. PubMed ID: 18816412 [Abstract] [Full Text] [Related]
5. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Debrie AS, Coutte L, Raze D, Mooi F, Alexander F, Gorringe A, Mielcarek N, Locht C. Vaccine; 2018 Mar 07; 36(11):1345-1352. PubMed ID: 29433898 [Abstract] [Full Text] [Related]
6. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation. Niinikoski V, Barkoff AM, Mertsola J, He Q. Clin Microbiol Infect; 2024 May 07; 30(5):683.e1-683.e3. PubMed ID: 38310999 [Abstract] [Full Text] [Related]
9. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis. Oguchi K, Miyata A, Kazuyama Y, Noda A, Suzuki E, Watanabe M, Nakayama T. J Infect Chemother; 2015 Sep 07; 21(9):639-46. PubMed ID: 26134278 [Abstract] [Full Text] [Related]
10. Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. Xu Y, Wang Y, Tan Y, Zhang H, Wu L, Wang L, Hou Q, Zhang S. BMC Microbiol; 2009 Dec 29; 9():274. PubMed ID: 20040101 [Abstract] [Full Text] [Related]
14. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. N Engl J Med; 1996 Feb 08; 334(6):349-55. PubMed ID: 8538705 [Abstract] [Full Text] [Related]
16. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. J Clin Microbiol; 2005 Jun 08; 43(6):2856-65. PubMed ID: 15956409 [Abstract] [Full Text] [Related]